Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K F Becker

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The American Journal of Pathology|September 1, 1995
Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family historyG Keller, M Rotter, H Vogelsang, et al.
Virchows Archiv : an International Journal of Pathology|July 8, 1999
Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterationsC Schuhmacher, I Becker, S Oswald, et al.
Oncogene|August 10, 1999
Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motilityG Handschuh, S Candidus, B Luber, et al.
British Journal of Cancer|March 13, 2014
Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancerK Malinowsky, U Nitsche, K-P Janssen, et al.
The American Journal of Pathology|December 14, 1999
Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibodyK F Becker, E Kremmer, M Eulitz, et al.
The American Journal of Pathology|August 6, 1999
Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutationG Keller, H Vogelsang, I Becker, et al.
British Journal of Cancer|July 11, 2013
A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomasJ Slotta-Huspenina, C Wolff, E Drecoll, et al.
Cancer Research|April 18, 2001
Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancerR Senekowitsch-Schmidtke, C Schuhmacher, K F Becker, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The American Journal of Pathology|September 1, 1995
Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family historyG Keller, M Rotter, H Vogelsang, et al.
Virchows Archiv : an International Journal of Pathology|July 8, 1999
Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterationsC Schuhmacher, I Becker, S Oswald, et al.
Oncogene|August 10, 1999
Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motilityG Handschuh, S Candidus, B Luber, et al.
British Journal of Cancer|March 13, 2014
Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancerK Malinowsky, U Nitsche, K-P Janssen, et al.
The American Journal of Pathology|December 14, 1999
Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibodyK F Becker, E Kremmer, M Eulitz, et al.
The American Journal of Pathology|August 6, 1999
Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutationG Keller, H Vogelsang, I Becker, et al.
British Journal of Cancer|July 11, 2013
A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomasJ Slotta-Huspenina, C Wolff, E Drecoll, et al.
Cancer Research|April 18, 2001
Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancerR Senekowitsch-Schmidtke, C Schuhmacher, K F Becker, et al.
Pageof 5